Ligand validation:6ZOG

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6ZOG_EDO_B_1108	73%	99%	0.105	0.931	0.07	0.14	-	-	0	0	100%	1
6ZOG_EDO_E_202	52%	98%	0.176	0.934	0.06	0.21	-	-	0	0	100%	1
6ZOG_EDO_E_201	28%	98%	0.233	0.885	0.07	0.18	-	-	0	0	100%	1
6ZOG_EDO_C_1306	19%	99%	0.247	0.846	0.08	0.12	-	-	0	0	100%	1
6ZOG_EDO_A_1104	14%	99%	0.286	0.841	0.07	0.17	-	-	0	0	100%	1
6ZOG_EDO_C_1307	5%	99%	0.352	0.75	0.06	0.17	-	-	0	0	100%	1
7OUK_EDO_B_1513	48%	99%	0.162	0.906	0.06	0.17	-	-	0	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
8JK3_EDO_A_304	100%	81%	0.033	0.992	0.22	0.58	-	-	0	0	100%	1
7CJO_EDO_B_1210	100%	83%	0.038	0.99	0.47	0.32	-	-	0	0	100%	1
4O78_EDO_A_202	100%	86%	0.043	0.992	0.4	0.33	-	-	0	0	100%	1
6QRS_EDO_A_401	100%	83%	0.045	0.991	0.47	0.31	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.